Evaluate ZTS stock safety — financial health, volatility, institutional backing, and risk factors.

What are the risks of investing in ZTS? | Glauxie AI

Q: What are the risks of investing in ZTS?

Zoetis Inc. (ZTS) operates in the Drug Manufacturers - General industry (Healthcare sector). The company is led by CEO Kristin C. Peck. Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products... Employees: 14,500.

Q: How much debt does ZTS have?

Review ZTS total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Q: Is ZTS a good long-term investment?

Evaluate ZTS as a long-term investment using fundamental scores, growth metrics, and risk assessment.

What are the risks of investing in ZTS?

🦉

Zoetis Inc. (ZTS)

Company Overview

Sector / IndustryHealthcare / Drug Manufacturers - General

CEOKristin C. Peck

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and...

Key Executives

Name	Title
Jamie Brannan	Executive Vice President & Chief Commercial Officer
Jared Shriver	President of U.S. Operations
Jeannette Ferran Astorga	Executive Vice President of Corporate Affairs & Chief Sustainability Officer
Julie A. Fuller	Executive Vice President, Chief Human Resources Officer & Global Operations
Keith Sarbaugh	Executive Vice President & Chief Digital and Technology Officer
Kristin C. Peck	Chief Executive Officer & Director

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

ZTS Profile Financials

Is ZTS stock safe? How much debt does ZTS have? Is ZTS a good long-term investment?